About: Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1996 (uk) im März 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1996 (ast) scientific article published on 01 March 1996 (en) գիտական հոդված հրատարակված 1996 թվականի մարտի 1-ին (hy)
publication date	wds:Q71447496-CF00BB2C-163B-4ACA-9AA0-49A1889D1DB2
publication date	1996-03-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71447496-23816902-189B-4D86-9752-A08A80A9C988 wds:Q71447496-39A475FB-BCE8-4B81-834C-2D9DED85DB55 wds:Q71447496-404CDBE2-2E7D-4CB6-A459-DA061730D98D wds:Q71447496-6D1F2661-3E10-4CAA-B650-7DE6CD97C424 wds:Q71447496-73B33650-3304-4D31-ABC5-68EADBE77D67 wds:Q71447496-ADA6F00C-8233-4E79-A9A9-98D5C2791ECE wds:Q71447496-BA50A2A0-A4FF-404F-8482-D498C98C4A2F wds:Q71447496-BAA91C18-9C56-412F-B60B-0C32CE775610 wds:Q71447496-BF17B043-132B-45BF-BD6C-5CCEE1B1A11A wds:Q71447496-CEC5BC9F-BC12-4012-95BC-4DAA6A49D65C wds:Q71447496-FF5DD0DB-FE12-466E-87D0-7A38B0F07A56
author name string	M Ek J M Cain L W Rice A F Fuller H G Muntz H K Tamimi R Sainz de la Cuesta B E Greer B A Goff N Nikrui D Fleischhacker
rdfs:label	Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (en) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (nl)
skos:prefLabel	Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (en) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (nl)
name	Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (en) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (nl)
title	wds:Q71447496-F436D752-15E3-4F30-89CC-FE9FC7B3A899
title	Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease (en)
page(s)	wds:Q71447496-AE13CAA5-CE8F-4E97-8A22-D6CB81E4F3C3
page(s)	412-417
instance of	wds:Q71447496-3020717A-2AED-4D2B-9C5B-FD02AF272F48
instance of	scholarly article
main subject	wds:Q71447496-3354FF4B-6478-446C-B766-8CCD16B322C8 wds:Q71447496-6846F2C5-F7DB-4039-86CD-DD25B4A6D39B wds:Q71447496-7CED9212-BC23-4673-B366-FF4FBB612073
main subject	platinum clear cell carcinoma chemotherapy
PubMed ID	wds:Q71447496-32235545-FC76-47F9-8594-004F9F6B488B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8774649
PubMed ID	8774649
published in	wds:Q71447496-AA360431-CFBE-4656-9290-E88F8BB6DC8B
published in	Gynecologic Oncology
issue	wds:Q71447496-00A50F40-B3C5-4127-9C2C-CC08784929AD
volume	wds:Q71447496-27AEC715-AD60-414F-B64A-17A245592696
issue	3
volume	60
DOI	wds:Q71447496-4D974A29-E543-4A6A-82E2-0B58F1EB141A
DOI	http://dx.doi.org/10.1006/GYNO.1996.0065
DOI	10.1006/GYNO.1996.0065
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71447496
is cites work of	Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas Silent venous thromboembolism before treatment in endometrial cancer and the risk factors Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis ARID1A mutations in endometriosis-associated ovarian carcinomas Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Pharmaceutical management of ovarian cancer : current status Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development Ovarian clear cell adenocarcinoma: a continuing enigma Clear cell carcinoma of the ovary: a review of the literature Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma Prognostic implication of endometriosis in clear cell carcinoma of the ovary Prognostic determinants in patients with uterine and ovarian clear carcinoma Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species Thromboembolic complications in patients with clear cell carcinoma of the ovary Recent progress in the diagnosis and treatment of ovarian cancer Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary Histologic types of epithelial ovarian cancer: have they different risk factors? Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software